About Robert Hasserjian, MD
Dr. Hasserjian's clinical work and research focus on myeloid neoplasia. He has served on the Executive Committee of the Society for Hematopathology and on the Education Committee of the United States and Canadian Academy of Pathology. Dr. Hasserjian is a member of the Pathology Advisory Committee for the World Health Organization Classification of Myeloid Neoplasms. Dr. Hasserjian is a dedicated medical educator, and director of the Hematopathology Fellowship at Massachusetts General Hospital.
Clinical Interests:
- Gastrointestinal (GI) pathology
- Hematopathology
Treats:
- Adult & Pediatrics
Languages:
- Armenian, French, German, Russian
Locations
Mass General Pathology
55 Fruit St.
Boston, MA 02114
Phone: 617-643-0800
Medical Education
- MD, Harvard Medical School*
- Residency, Brigham and Women's Hospital
- Fellowship, Brigham and Women's Hospital
American Board Certifications
- Anatomic Pathology, American Board of Pathology
- Hematology, American Board of Pathology
Accepted Insurance Plans
- Aetna
- Beech Street
- Blue Cross Blue Shield
- Blue Cross Blue Shield Medicare
- Cigna
- Commonwealth Care Alliance
- Coventry
- Fallon Health
- Harvard Pilgrim Health Care
- Humana
- Maine Community Health Options
- Mass General Brigham Health Plan
- MassHealth
- Medicaid ME
- Medicaid NH
- Medicaid RI
- Medicaid VT
- Medicare
- Medicare ACO
- Multiplan
- Railroad Medicare
- Senior Whole Health
- TriCare
- Tufts Health Plan
- United Health Care
- Wellpoint
- WellSense
- WellSense NH
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Research
Dr. Hasserjian's research interests include:
- Molecular mechanisms of leukemia and lymphoma.
- Novel pathologic, immunophenotypic, and molecular prognostic markers in myelodysplastic and myeloproliferative diseases, leukemias, and lymphomas
For more information about research concepts, co-authors, and to see a timeline, visit Dr. Hasserjian???s profile at the Harvard Clinical and Translational Science Center.
Publications
-
- Chronic lymphocytic leukemia/small lymphocytic lymphoma: another neoplasm related to the B-cell follicle? Tandon B, Swerdlow SH, Hasserjian RP, Surti U, Gibson SE.Leuk Lymphoma. 2015 Apr 10:1-33. [Epub ahead of print]
- Routine conventional karyotyping of lymphoma staging bone marrow samples does not contribute clinically relevant information. Nardi V, Pulluqi O, Abramson JS, Dal Cin P, Hasserjian RP. Am J Hematol. 2015 Mar 16.[Epub ahead of print]
- Allo-SCT for myelofibrosis: reversing the chronic phase in the JAK inhibitor era? Tamari R, Mughal TI, Rondelli D, Hasserjian R, Gupta V, Odenike O, Fauble V, Finazzi G, Pane F, Mascarenhas J, Prchal J, Giralt S, Hoffman R. Bone Marrow Transplant. 2015 Feb 9. doi: 10.1038/bmt.2014.323. [Epub ahead of print]
Reviews: Comments and Ratings
Patient Gateway
Secure online access to your health information whenever you need it. Check appointments, communicate with your provider and pay bills online 24/7.
Adolescent and Young Adult (AYA) Cancer Program
The Adolescent and Young Adult Cancer Program was created to optimize the care, outcomes, and experiences of adolescent and young adult patients.
A Top Hospital in America
Mass General is recognized as a top hospital on the U.S. News Best Hospitals Honor Roll for 2024-2025.